Dermatological findings inSARS-CoV-2 positive patients: An observational study from North India
Dermatological findings inSARS-CoV-2 positive patients: An observational study from North India
复制标题
DOI：
10.1111/dth.13849
复制
发表时间：
2020-07-06
影响因子：
3.6
通讯作者：
Beniwal, Ravi
中科院分区：
文献类型：
--
作者：
Dalal, Ashish;Jakhar, Deepak;Beniwal, Ravi
一种新型冠状病毒（严重急性呼吸综合征冠状病毒-2; SARS-CoV-2）已经影响了世界各地数百万人。由SARS-CoV-2引起的冠状病毒病（COVID-19）表现出不同的临床严重程度，具有呼吸道和呼吸道外症状。COVID-19的皮肤病学表现报告很少。研究印度人群中SARS-CoV-2阳性患者的各种皮肤病学表现。该研究获得了机构伦理委员会的许可，102名SARS-CoV-2阳性患者被纳入研究。进行了彻底的临床检查，以确定这些患者各种皮肤病表现的性质和频率。在102例阳性病例中，95例为男性。该组的平均年龄为39.30岁。13例（12.7%）患者被发现有皮肤病学表现。3例（2.9%）患者出现斑丘疹，2例（1.9%）患者出现荨麻疹病变，8例（7.8%）患者出现瘙痒，无任何特定皮肤体征。躯干是最常见的受累部位，其次是四肢。未检测到粘膜体征和症状。在一小群COVID-19患者中观察到皮肤病学表现。在不同的人群中，根据疾病的严重程度，其表现可能会有所不同。
A novel coronavirus (severe acute respiratory syndrome corononavirus-2; SARS-CoV-2) has affected millions of people across the world. The coronavirus disease (COVID-19) resulting from SARS-CoV-2 manifests in variable clinical severity, featuring both respiratory and extra-respiratory symptoms. Dermatological manifestations of COVID-19 are sparsely reported. To study the various dermatological findings in SARS-CoV-2 positive patients in Indian population. Institutional ethical committee permission was sought and102 SARS-CoV-2 positive patients were included in the study. A thorough clinical examination was done to determine the nature and frequency of various dermatological manifestations in these patients. Out of the 102 positive cases, 95 were males. The mean age of the group was 39.30 years. Thirteen patients (12.7%) were found to have dermatological manifestations. Three (2.9%) had maculopapular rash, two (1.9%) had urticarial lesions and eight (7.8%) patients had itching without any specific cutaneous signs. Trunk was the most frequently affected area, followed by the extremities. No mucosal signs and symptoms were detected. Dermatological manifestations were seen in a small group of COVID-19 patients. The presentation may vary in different population groups and based on severity of disease.